Syngene International is a global Contract Research Organization offering a integrated, end-to-end discovery and development services for novel molecular entities across small molecules, large molecules, antibody-drug conjugates and oligonucleotides. It includes medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation/analytical development with Clinical development services.